Chronic Total Occlusion
23
1
1
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.3%
1 terminated out of 23 trials
90.9%
+4.4% vs benchmark
9%
2 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (23)
CABG Versus PCI in Patients With Isolated LAD Chronic Total Occlusion
Sapphire 3 CTO Study
Impact of CTO PCI (Chronic Total Occlusion Percutaneous Intervention) on Regular Physical Activity
Risk Factors and Outcomes in Coronary Chronic Total Occlusion
CTO-PCI in Heart Failure Patients
Antiplatelet Therapy After Successful Percutaneous Coronary Intervention for Chronically Occluded Coronary Artery
Investigating the Utility of Remote Index of Microvascular Resistance in Patients With Chronic Total Occlusion
Chronic Total Occlusive Lesions CMR Study
Clinical Study Evaluating Use of the CapBuster Medical Device System for the Crossing of Chronic Total Occlusions
Chronic Total Occlusion Percutaneous Coronary Intervention Study
Decreasing Patient Anxiety During Revascularization of Chronic Total Coronary Occlusions Using Virtual Reality Glasses.
Use of Drug-Coated Balloon to Improve Recanalization of a Coronary Chronic Total Occlusion After Failed Angioplasty
Evaluation of the Radiological Dose Delivered to Risky Interventional Cardiology Patients (Optidose)
Registry Study to Evaluate the Performance and Safety of Roxwood Medical Catheters in Arteries of Participants With a Stenotic Lesion or Chronic Total Occlusion (CTO)
A Single Center Study to Evaluate the Safety of the NovaCross Microcatheter in Crossing Chronic Total Occlusions
Coronary Interventions Ulm - Coronary Chronic Total Occlusions
German Epicardial Collateral CTO Registry
STENTYS Xposition S in the Treatment of Chronic Total Artery Occlusion
Consistent CTO Trial
A Prospective, Non-randomized Study to Evaluate the Safety and Performance of the NovaCross™ Microcatheter in Femoropopliteal Chronic Total Occlusion (CTO).